• A Hybrid Conference and Internet Event
• Sponsored by the Asia Pacific Healthcare Industry Compliance Team and cosponsored by the Pharmaceutical Compliance Forum
• Onsite at the Intercontinental Shanghai Pudong Hotel in Shanghai, China
• Online In Your Own Office or Home live via the Internet with 24/7 Access for Six Months
• September 11 - 12, 2012
• www.AsianPharmaCongress.com

SHANGHAI -- CME UPDATE NEWS SERVICE™ -- JUNE 20, 2012: The Second Asia Pacific Pharmaceutical Compliance Congress, www.AsianPharmaCongress.com, September 11 - 12, 2012, will be held at the Intercontinental Shanghai Pudong Hotel in Shanghai, China. The Asia Pacific Pharma Congress is sponsored by the Asia Pacific Healthcare Industry Compliance Team and cosponsored by the Pharmaceutical Compliance Forum. Registrants may attend the event in person or online (live webcast and archived for 6 months).

FEATURING MYANMAR MARKET ACCESS & COMPLIANCE UPDATE BY

James Finch, Esq. Partner and Head of Myanmar Office, DFDL/Myanmar Thanlwin Legal Services Ltd., Yangon, Myanmar

SECOND ASIA PACIFIC PHARMACEUTICAL COMPLIANCE CONGRESS AND BEST PRACTICES FORUM September 11 - 13, 2012
ONSITE Intercontinental Shanghai Pudong Hotel Shanghai, China	OR	ONLINE In your own office or home live via the Internet with 24/7 access for six months

KEYNOTE SPEAKERS

Reinhard Angelmar, PhD Salmon and Rameau Fellow of Healthcare, Management Professor of Marketing, INSEAD, Appointments, Sloan School (MIT), Stockholm School of Economics, ESSEC Business School, and Universite Paris Dauphine, Fontainebleau, France Eric Baclet President and General Manager, Lilly China, EBP (Ethical Business Practice) Executive Sponsor, R&D-based Pharmaceutical Association Committee (RDPAC), Former Vice President of Global Marketing, Lilly Neuroscience, Shanghai, China Jane de Lozey, Esq. Joint Head of Fraud, Serious Fraud Office, London, UK Yong Hu, Esq. Head, Legal Affairs Department, Sinopharm Group Co. Ltd., Largest Medical and Healthcare Group in China; Directly Managed by State-owned, Assets Supervision and Administration Commission of the State Council (SASAC), Beijing, China Mark Mallon, MBA Regional Vice President Asia Pacific and President China, AstraZeneca, Former Executive Vice-President and Chief Operating Officer, AstraZeneca KK (Japan), Shanghai, China Xu Ming Vice President, China Chamber of Commerce for Import & Export of Medicines & Health Products (CCCMHPIE), Beijing, China

FEATURING CHINA COMPLIANCE BEST PRACTICES PANEL

Cynthia Chen Compliance Director, Boehringer Ingelheim, Shanghai, China Jennifer Chen, Esq. Legal Director, RDPAC, Shanghai, China Jane Huang, LLM Senior Legal Counsel and Compliance Director, Eli Lilly, Shanghai, China Kristin Yang, Esq. Ethics and Compliance Counsel, Baxter International, Former General Counsel, Greater China Region, Carestream Health, Former Legal Counsel, Eli Lilly, Shanghai, China Shine Yao, MIM Compliance Director, Merck, Shanghai, China Eva Yin China/HK Compliance Officer, AstraZeneca, Shanghai, China John Auerbach, MA Partner, Fraud Investigation & Dispute Services, Ernst & Young, Shanghai, China (Moderator)

INDOCHINA COMPLIANCE UPDATE, INCLUDING CAMBODIA, LAOS, THAILAND AND VIETNAM

Praween Chantanakomes, Esq. Lawyer, Baker & McKenzie, Bangkok, Thailand Seck Yee Chung Partner, Baker & McKenzie (Vietnam) Ltd., Ho Chi Minh City, Socialist Republic of Vietnam Michelle Y. L. Gon, Esq. Partner, Baker & McKenzie, Shanghai, China Kitchrat Kontain, LLM, MBA Lawyer, South East Asia Law Office, Vientiane, Laos Bretton G. Sciaroni, Esq. Partner, Sciaroni & Associates, Chair, International Business Chamber of Cambodia, Phnom Penh, Cambodia Peerapan Tungsuwan, LLM Partner, Baker & McKenzie, Bangkok, Thailand

FEATURED FACULTY

Ted Acosta, Esq. Principal, Ernst & Young LLP, Former Senior Counsel, Office of Inspector General, US Department of Health and Human Services, New York, NY, USA and Paris, France Eugene Chen, Esq. Counsel, Hogan Lovells International LLP, Shanghai, China Hui Chen, Esq. Senior Corporate Counsel, Asia-Pacific Regional Lead, International Compliance Investigations, Pfizer, New York, NY, USA Hwa-Soo Chung, Esq. Chair, Health Law Group, Kim & Chang Law Firm, Seoul, South Korea Emma Davies, Esq. Partner, Clifford Chance LLP, Singapore Fred Eaton, MBA Partner, Polaris Management Partners, New York, NY Sue Egan Director and Principal Consultant, Sue Egan Associates; Editor, Life Science Compliance; Former Vice President Compliance, AstraZeneca, Great Missenden, Buckinghamshire, UK Karen Eryou Director and Head, Quality & Compliance, UCB Pharma - Greater China and SE Asia, Shanghai, China James Finch, Esq. Partner and Head of Myanmar Office, DFDL/Myanmar Thanlwin Legal Services Ltd., Yangon, Myanmar Joanna Gao, LLM Area Compliance Officer, Internal Audit Director, GlaxoSmithKline China/HK, Beijing, China Erinn Hutchinson Partner, Global Pharmaceuticals and Life Sciences PricewaterhouseCoopers, Philadelphia, PA, USA Jonathon Kellerman Principal, Pharmaceutical and Life Sciences Advisory Services, PricewaterhouseCoopers LLP, Florham Park, NJ, USA Amar Kureishi, MD Chief Medical Officer and Head of Strategic, Drug Development in Asia-Pacific, Quintiles, Former Global Head of Medical Affairs, Bayer, Singapore Glen Ma, Esq. Partner, Clifford Chance, Shanghai, China Marc L. Miller Partner, KPMG LLP, New York, NY, USA Audrey Mills, Esq. Consultant, EMBU Ethics and Compliance, Eli Lilly and Company, Indianapolis, IN, USA Yoshiki Nagase, LLB, LLM Senior Director, Country-Lead Health Care Compliance Japan, Johnson & Johnson, Former Senior Regulatory Counsel, Asia, Standard & Poor's, Former Deputy Head of Compliance, Bear Stearns, Former Head of Legal & Compliance, ING, Tokyo, Japan Brian Riewerts Partner, Global Pharmaceuticals and Life Sciences, PricewaterhouseCoopers LLP, Baltimore, MD, USA Vivian Robinson, Esq. Partner, McGuireWoods, Former General Counsel of the UK Serious Fraud Office Former Head, QEB Hollis Whiteman Chambers, Recorder of the Crown Court and Treasurer of Inner Temple, London, UK Arpinder Singh Partner and National Director, Fraud Investigation & Dispute Services, Ernst & Young, President, Mumbai Chapter, Association of Certified Fraud Examiners (ACFE), Mumbai, India Trudy Tan Regional Compliance Director, AstraZeneca, Singapore Yuet-Ming Tham, Esq. Partner, Sidley Austin LLP, Former Regional Compliance Director, Legal Division, Corporate Compliance, Pfizer Inc., Hong Kong Joseph B. Tompkins, Jr. Partner, Sidley Austin LLP; Former Deputy Chief of the Fraud Section, Criminal Division, United States Department of Justice, Washington, DC, USA Mai Tran Executive Vice President of Health & Wellness, Ruder Finn Asia, Shanghai, China Katherine Wang, JD, LLM Counsel, Global Life Sciences Practice, Sidley Austin LLP, Shanghai, China Jun Wei, Esq. Managing Partner, Beijing Office, Hogan Lovells International LLP, Beijing, China Chen Yang, Esq. Partner and Head, China Life Sciences Practice, Sidley Austin LLP, Former Legislative Official, Bureau of Legislative Affairs, Chinese State Council, Beijing, China Tom M. Zerull Senior Manager Ethics & Compliance, International Operations, Abbott, Singapore Kang Zhuang Finance Director, Controller, Pfizer Investment Co. Ltd., Beijing, China

OTHER INTERNATIONAL PHARMA CONGRESSES

2007 - Brussels 2008 - Paris 2009 - Rome 2010 - Berlin 2011 - Istanbul 2011 - Singapore 2012 - Budapest 2012 - Shanghai 2012 - São Paulo

The Pharmaceutical Compliance Forum (PCF) is a coalition of senior compliance professionals and legal counsel from more than 50 of the largest research-based pharmaceutical manufacturers. The PCF was founded in early-1999 by compliance professionals from the pharmaceutical industry to promote effective corporate compliance programs.

The Asia Pacific Healthcare Industry Compliance Team is an ad hoc, voluntary group of Asia Pacific pharmaceutical, medical device and other life sciences company compliance professionals and legal counsel who meet quarterly to discuss legal and compliance issues and best practices.